EUVIMED · CrossrefZeitschrift
JNCI Cancer Spectrum
ISSN 2515-5091 · Oxford University Press (OUP)
Neueste Artikel
Quantifying cancer clinical trial eligibility using artificial Intelligence-Based matching
B-cell activation markers and cancer risk in people with HIV: An integrative case-control and Mendelian randomization analysis
Determinants of prostate-specific antigen levels in African men
Endocrine therapy adherence and 10-year cardiometabolic risk in hormone receptor-positive breast cancer
Platform-agnostic quantification for molecular interception of oral and esophageal malignancies: a global study addressing the diagnostic divide
Provider communication about colorectal cancer screening tests among US adults
Plasma metabolomic profiles associated with breastfeeding history and subsequent ovarian cancer risk
When actionable genomic findings do not translate into treatment in precision oncology
Angiographic findings, revascularisations and mortality in childhood cancer survivors with ischaemic heart disease
Evaluating the unintended uptake of lung cancer screening
Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32
Challenges in medical algorithmic fairness
Swedish matched cohort on the association between maternal polyendocrine metabolic ovarian syndrome and next-generation cancer risk
Trends in adult exclusive and dual use of combustible and non-combustible tobacco products in the United States
Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivors
Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer
Racial disparities and utilization trends of first-line targeted therapies for metastatic breast cancer
Personalized risk prediction of financial toxicity in patients with cancer: an interpretable machine learning study
Heterogeneous treatment effect of immune checkpoint inhibitors by pretreatment prognosis in randomized controlled trials
Chronic exercise training intensity, immune cells, and cancer outcomes: a scoping review
Disparities in cardiometabolic and cardiovascular risk after breast cancer: the Pathways Heart Study
Body mass index and chemotherapy completion among patients with newly diagnosed ovarian cancer
Perioperative chemoimmunotherapy for patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysis
The cervical cancer divide: state variation in incidence, mortality, and progress toward elimination in the United States
Availability of multidisciplinary treatment modalities and outcomes among patients with resected early-stage non-small cell lung cancer
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world data
Extending catchment area approaches to a community cancer center: a breast cancer hotspot case study
The mediating role of physical activity on cognitive disparities in cancer survivors
Risks of colorectal and extracolonic cancers following colorectal cancer: a systematic review and meta-analysis
General practitioner–led vs surgeon-led colon cancer survivorship care: a randomized clinical trial
EUVIMED